| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | INCYTE | 14,865,559 | 1,549,140,000 | 13.59% | ||
| 2 | SEATTLE GENETICS INC | 30,870,262 | 1,494,121,000 | 13.11% | ||
| 3 | ALEXION PHARMACEUTIC | 6,542,599 | 1,182,706,000 | 10.37% | ||
| 4 | ABBVIE INC | 14,373,538 | 965,758,000 | 8.47% | ||
| 5 | ACADIA PHARMACEUTICALS INC COM | 20,481,442 | 857,763,000 | 7.52% | ||
| 6 | Incyte Corporation | 274,500,000 | 567,758,000 | 4.98% | PRN | |
| 7 | BIOMARIN | 4,095,247 | 560,148,000 | 4.91% | ||
| 8 | Incyte Corporation | 259,000,000 | 529,519,000 | 4.64% | PRN | |
| 9 | INCYTE CORP SR NT CONV 4.750% 10/01/15 B/EDTD 03/30/10 0221 UBS FINANCIAL SERVICES INC. A/C MR06471 | 40,446,000 | 478,833,000 | 4.20% | PRN | |
| 10 | GENOMIC HEALTH INC COM | 13,657,598 | 379,545,000 | 3.33% | ||
| 11 | Anacor Pharmaceuticals Inc | 3,625,498 | 280,722,000 | 2.46% | ||
| 12 | DYAX CORP COM CVR | 7,926,630 | 210,056,000 | 1.84% | ||
| 13 | BIOCRYST PHARMACEUTICALS | 11,577,299 | 172,849,000 | 1.52% | ||
| 14 | BIOMARIN PHARMACEUTICAL INC | 22,379,000 | 149,970,000 | 1.32% | PRN | |
| 15 | GILEAD SCIENCES | 20,944,000 | 107,926,000 | 0.95% | PRN | |
| 16 | INVITAE CORP | 6,554,967 | 97,538,000 | 0.86% | ||
| 17 | BELLICUM PHARMACEUTICALS INC COM | 4,190,594 | 89,134,000 | 0.78% | ||
| 18 | MIRATI THERAPEUTICS INC COM | 2,805,074 | 88,276,000 | 0.77% | ||
| 19 | HERON THERAPEUTICS INC | 2,807,784 | 87,491,000 | 0.77% | ||
| 20 | SPARK THERAPEUTICS INC | 1,262,382 | 76,084,000 | 0.67% | ||
| 21 | Medivation Inc 04/01/2017 2.625% | 33,889,000 | 75,011,000 | 0.66% | PRN | |
| 22 | CERUS CORP | 13,553,275 | 70,341,000 | 0.62% | ||
| 23 | ACORDA THERAPEUTICS INC | 59,583,000 | 60,049,000 | 0.53% | PRN | |
| 24 | XOMA CORP DEL | 14,683,513 | 56,972,000 | 0.50% | ||
| 25 | DBV TECHNOLOGIES | 1,862,019 | 55,451,000 | 0.49% | ||
| 26 | VERSARTIS INC COM | 3,436,585 | 52,305,000 | 0.46% | ||
| 27 | ALDER BIOPHARMACEUTICALS INC | 891,688 | 47,233,000 | 0.41% | ||
| 28 | HALOZYME THERAPEUTICS INC | 1,931,057 | 43,603,000 | 0.38% | ||
| 29 | Life Technologies Corp | 2,335,125 | 43,247,000 | 0.38% | ||
| 30 | XENOPORT INC | 6,508,622 | 39,898,000 | 0.35% | ||
| 31 | ARRAY BIOPHARMA INC COM | 5,482,505 | 39,529,000 | 0.35% | ||
| 32 | INSMED INC COM PAR .01 | 1,583,490 | 38,669,000 | 0.34% | ||
| 33 | SANGAMO BIOSCIENCES INCORPORATED | 3,230,932 | 35,831,000 | 0.31% | ||
| 34 | IMMUNOGEN INCORPORATED | 2,320,424 | 33,368,000 | 0.29% | ||
| 35 | TG THERAPEUTICS INC COM | 2,003,991 | 33,246,000 | 0.29% | ||
| 36 | PROGENICS PHARMACEUTICALS IN | 4,350,808 | 32,457,000 | 0.28% | ||
| 37 | CATALYST PHARMACEUTICALS INC | 7,335,692 | 30,296,000 | 0.27% | ||
| 38 | GILEAD SCIENCES INC | 249,995 | 29,269,000 | 0.26% | ||
| 39 | KYTHERA BIOPHARMACEUTICALS I | 387,741 | 29,201,000 | 0.26% | ||
| 40 | NEUROCRINE BIOSCIE COM USD0.001 | 542,236 | 25,897,000 | 0.23% | ||
| 41 | IDERA PHARMACEUTICALS INC | 6,970,902 | 25,862,000 | 0.23% | ||
| 42 | BLUEBIRD BIO INCORPORATED | 151,105 | 25,442,000 | 0.22% | ||
| 43 | DERMA SCIENCES INC COM PAR .01 | 3,457,841 | 24,758,000 | 0.22% | ||
| 44 | ACORDA THERAPEUTICS | 738,916 | 24,628,000 | 0.22% | ||
| 45 | NOVAVAX INC COM | 1,945,687 | 21,675,000 | 0.19% | ||
| 46 | Foamix Pharmaceuticals Ltd. | 2,046,967 | 20,981,000 | 0.18% | ||
| 47 | XENCOR INC COM | 872,072 | 19,159,000 | 0.17% | ||
| 48 | GALAPAGOS NV | 369,276 | 19,018,000 | 0.17% | ||
| 49 | BIOMARIN PHARMACEUTICAL INC | 12,228,000 | 18,940,000 | 0.17% | PRN | |
| 50 | CLOVIS ONCOLOGY INC | 202,630 | 17,807,000 | 0.16% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-15-049845, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
